Table 1.
Preparation | Derivation | Syncytia blocking | IC90 μM | Biologic activity | N-terminal sequence | C-terminal sequence |
---|---|---|---|---|---|---|
SDF1-α 1–67 | Synthetic | + | ≤0.12 | +* | KPVSLSYR | ALN |
SDF1-α 6–67 | Synthetic | ND | ND | −† | SYR | ALN |
SDF1-α 1–68 | Recombinant | + | ≤0.13 | +‡ | KPVSLSYR | ALNK |
SDF1-α −2 to 68 | Synthetic | − | ≥1.6 | +§ | DGKPVSLSYR | ALNK |
SDF1-β 1–72 | Recombinant | + | ≤0.11 | +‡ | KPVSLSYR | ALNKKRFM |
SDF1-β −3 to 72 | Recombinant | − | ≥1.0 | +¶ | SDGKPVSLSYR | ALNKKRFM |
The sources of the preparations are given in Materials and Methods.
Measured by chemotaxis of human lymphocytes; maximal at ≈125 nm (26).
Measured by chemotaxis of human lymphocytes; inactive up to ≈1 μM (26).
Measured by microphysiometer in Jurkat T cells EC50 ≈100 nM (R.H and M. Liang unpublished data).
Measured by chemotaxis in human hNT neurons EC50 ≈50 nM (33).
Measured by chemotaxis of human T-lymphocytes in IL-2 for 8-10 days, ED50 ≈ 60 nM (R & D Systems).